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Abstract
The aerial  parts  of  Guarea guidonia afforded  three new tirucallane-type triterpenoids  3,4-seco-
tirucalla-4(28),8(9),24(25)-trien-7α,11α-dihydroxy-21,23-epoxy-3,11-olide,  named guareolide (1),
3,4-seco-tirucalla-4(28),7(8),24(25)-trien-21-hydroxy-21,23-epoxy-3-oic acid, named guareoic acid
A (2), and 3,4-seco-tirucalla-4(28),7(8),24(25)-trien-21,23-epoxy-3-oic acid, named guareoic acid B
(3), of which  1 possessed an unusual seven-membered lactone ring. Seven known terpenes were
also isolated and characterized as flindissone, 7-acetyldihydronomilin, picroquassin E, boscartol C,
and cneorubins A, B, and X. Their structures were determined by spectroscopic methods including
1D and 2D NMR analysis and high resolution mass spectrometry. The isolates were investigated for
their potential  cytotoxic activity  on  Jurkat,  HeLa,  and MCF7 cancer  cell  lines.  Flindissone and
compound  2 showed an  antiproliferative  activity  in  all  cell  lines.  Further  studies  revealed  that
flindissone,  the  most  active  compound, induced  in  Jurkat  and  HeLa  cells  both  cytostatic  and
cytotoxic responses. 
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Introduction 
Guarea is a genus of the Meliaceae family which is among the richest and most diverse sources of
secondary metabolites in the Angiospermae, with 50 genera and more than 1400 species.  Guarea
genus  comprised  both  trees  or  small  shrubs  with  about  80  species  widespread  in  Africa  and
America countries; eight species of this genus were classified in the wet forest of Venezuela [1].
Guarea  guidonia (L.)  Sleumer  is  a  tree  typical  of  Brazil  but  it  is  also  found  in  Venezuela,
particularly in the Sierra Parima of the Estado Bolivar, where the wood bark is traditionally used as
a febrifugal agent and an abortive, while the leaves and the fruits are known to be toxic for the cattle
[2,3].
Limonoids, triterpenes, steroids, sesquiterpenes, diterpenes, and coumarins are typical constituents
of  this  species  [3].  The  aerial  parts  of  this  plant  were  already  investigated  and  different
compositions have been found for specimens collected in different regions [4]. In our continuing
investigations on Venezuelan Meliaceae plants [5,6], the phytochemical study of G. guidonia aerial
parts was carried out and three new tirucallane-type triterpenoids (1-3) (Fig. 1) were isolated and
characterized, together with seven known compounds. In the framework of a research project aimed
to investigate the cytotoxic activity of plant small molecules, all the isolates were assayed.
Results and Discussion
The  n-hexane  and  chloroform aerial  parts  extract  of  G. guidonia  were  repeatedly  subjected  to
different chromatographies to afford three new tirucallane-type triterpenes (1-3) (Fig. 1), along with
seven known compounds.
Compound 1 showed a sodiated molecular ion peak at m/z 491.3122 for [M+Na]+ in the HRESIMS,
allowing the assignment of molecular formula C30H44O4. The 
1H NMR of 1 (Table 1) showed the
presence  of  six  methyl  singlets,  three  of  which  on  double  bonds  (δ 1.72,  1.73,  and  1.82),  an
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exomethylene  group  (δ 4.80,  5.01),  one  resonance  for  olefinic  proton  (δ 5.24),  three
hydroxymethines (δ 4.12, 4.67, 5.18),  and one hydroxymethylene (δ 3.24, 4.15).  The  13C NMR
(Table 1) displayed 30 carbon signals that were assigned as six methyls (δ 18.3, 19.7, 20.2, 24.0,
25.9 double signal), seven methylenes (δ 28.3, 30.5, 30.8, 35.0, 35.3, 39.1, 39.3), three methines
(δ . , . , .434 469 497  ), three quaternary carbons (δ 41.5, 43.0, 52.4), one methylene double
bond (δ 115.8, 148.0), one trisubstituted double bond (δ 127.6, 138.0), one tetrasubstituted double
bond (δ 133.2,  145.8),  three  oxygenated  methyne carbons  (δ 64.0,  75.1,  76.0),  one  oxygenated
methylene carbon (δ 72.8), and one carboxyl group (δ 178.0). Results obtained from 1D TOCSY
and COSY experiments established the correlations of all protons in 1, showing the sequences H-1
—H-2,  H-5—H-7,  H-11—H-12,  H-15—H-21,  H-15—H-23.  Full  assignments  of  all  protonated
carbon signals were secured by HSQC and HMBC NMR interpretation. The HMBC correlations
between  δ 5.18 (H-11) and  δ 133.2 (C-9), 145.8 (C-8), and 178.0 (C-3), and  δ 1.96 (H-1a) and
δ  20.2 (Me-19), 41.5 (C-10), 133.2 (C-9), 178.0 (C-3), suggested that the hydromethine group at C-
11 was involved in an unusual lactone ring with C-3. Other key cross peaks were observed between
δ 0.93 (Me-30) and δ 145.8 (C-8) confirming the presence of a C-8/C-9 double bond. The chemical
shifts of H2-21 and H-23 suggested the presence of an epoxy function at these positions, forming a
tetrahydrofuran ring in the side chain, while C-24—C-27 formed an isobutenoyl group [7]. The
relative stereochemistry of  1 was determined by 1D-ROESY experiments  and comparison with
literature data. The signal characteristic of H-7 (br s) and its 1D-ROESY correlation with  δ 0.93
(Me-30) demonstrated an α-orientation for the 7-OH group. Selective irradiation of H-11 (δ 5.18)
showed significant enhancement of the methyl signal at  δ 1.09 (Me-19) and of H-2β;  similarly
irradiation of δ 1.09 (Me-19) produced enhancement of H-11 and H-7 signals. In the light of these
data,  the  structure  of  1 was  elucidated  as  3,4-seco-tirucalla-4(28),8(9),24(25)-trien-7α,11α-
dihydroxy-21,23-epoxy-3,11-olide and was named guareolide. To the best of our knowledge, this is
the first report of a tirucallane-type triterpene with an unusual seven-membered lactone ring.
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The molecular  formula of  C30H46O4  was assigned to  compound  2,  obtained as white amorphous
powder, by its negative HRESIMS spectrum (m/z 469.6838 [M-H]-). Analysis of 1H and 13C NMR
data (Table 1) suggested a triterpenoid structure. The 13C, HSQC, and HMBC NMR spectra of  2
showed  30  carbon  signals,  indicative  of  six  methyls,  eight  methylenes,  four  methines,  three
quaternary carbons, an exomethylene group, two trisubstituted double bonds, one hydroxymethine,
a carboxyl group, and an emiacetal function. These data led to establish the presence of a seco-ring
A tirucallane triterpene [8]. COSY and 1D TOCSY experiments, together with HMBC cross peaks
correlations  between  H-5—C-1,  H-5—C-4,  H-5—C-28,  Me-29—C-4,  Me-29—C-5,  further
confirmed the 3,4-seco-A-ring form in 2. The 1H NMR spectrum of 2 revealed the presence of six
singlet  methyl groups of which three were linked to double bonds,  two resonances  for  olefinic
hydrogens,  two protons for  an exocyclic  double bond, one hydroxymethine,  and one emiacetal
function  (Table  1).  A  spin  system,  CH(17)−CH(20)−CHOH(21)  and
CH(17)−CH(20)−CH2(22)−CH(23)−CH(24),  determined  from  the  COSY  spectrum,  suggested
associations of C-21 with C-20 and C-24, which would require a five-membered ring anchored at
C-17. This finding was confirmed by the HMBC correlations of H-17 (δH 2.11) with C-20 (δC 49.0),
H-20 (δH 2.02) with C-17 (δC 46.0) and C-21 (δC 104.0), H-21 (δH 4.83) with C-22 (δC 37.0), C-20
(δC 49.0), and C-23 (δC 76.4). The HMBC correlations from the proton signals at δH 1.69 (Me-26)
and  1.72  (Me-27)  to  the  carbon  signals  at  δC 128.9  (C-24)  and  135.0  (C-25)  supported  the
occurrence  of  an isobutenyl group at  C-23 [7].  The relative stereochemistry of  2 was obtained
through 1D-ROESY correlations between δ 1.06 (Me-30) and 0.86 (Me-19) and δ 0.94 (Me-18) and
2.02 (H-20). Furthermore, similar 1H and 1D-ROESY NMR data showed the relative configuration
of the side chain in 2 to be the same as 3-epi-flindlissol [7]. Therefore, compound 2 was identified
as 3,4-seco-tirucalla-4(28),7(8),24(25)-trien-21-hydroxy-21,23-epoxy-3-oic acid, named as guareoic
acid A.
Compound 3 was purified as a white amorphous powder. Its molecular formula was determined to
be C30H46O3 from the deprotonated molecular ion [M-H]
- at m/z 453.3329 in the negative HRESIMS
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spectrum. Analysis of its NMR spectra (Table 1) suggested the same 3,4-seco-tirucallane skeleton
described for  1. Comparison of NMR spectra with those of  2 revealed  3 to differ from 2 only by
functionalities of ring E. In fact, in compound 3 the chemical shifts of H2-21 at δ 4.01 (1H, t, J = 8.3
Hz) and 3.28 (1H, br t, J = 9.2 Hz), and H-23 at δ 4.65 (1H, ddd, J = 13.3, 8.5, 4.6 Hz) suggested
that  the  emiacetal  function  at  C-21  was  replaced  by a  hydroxymethylene  group [9].  Thus,  the
structure  of  3,4-seco-tirucalla-4(28),7(8),24(25)-trien-21,23-epoxy-3-oic  acid was  determined for
compound 3 and was named guareoic acid B.
Flindissone  [10],  7-acetyldihydronomilin  [11],  picroquassin  E  [12],  boscartol  C  [13],  and
cneorubins  A,  B,  and  X [14]  were  also  purified  and  identified  by  comparison  with  published
spectroscopic data.
The  antiproliferative  activity  of  the  isolates  was  evaluated  in  Jurkat  (T-cell  leukemia),  HeLa
(cervical carcinoma), and MCF-7 (breast cancer) cancer cell lines by ([3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl  tetrazolium bromide])  (MTT)  assay.  Half  maximal  inhibitory  concentration  (IC50)
values, obtained from dose-response curves, are shown in  Table 2. Compound 2 and flindissone
showed  an  antiproliferative  activity  in  all  cell  lines.  In  particular,  Jurkat  resulted  slight  more
susceptible than HeLa, and HeLa than MCF7 cells. Furthermore, the cytotoxic potential of active
compounds was evaluated in Human peripheral  blood mononuclear  cells  (PBMC) from healthy
donors, chosen as the normal counterpart of leukemia-derived Jurkat cell line. Compound  2 and
flindissone did  not  causes  any  significant  reduction  of  the  number  of  freshly  isolated  non-
proliferating PBMC, at least in the range of cytotoxic doses in leukemia cells.
The mechanism(s) underlying the antiproliferative effect of the most active flindissone was further
studied  in  HeLa  and  Jurkat  cells.  To  investigate  whether  flindissone reduced  cells  number  by
affecting cell cycle progression and/or by inducing cell death, HeLa and Jurkat cells were exposed
for 48 h to concentrations (15 and 35 µM) close to the EC50 value of flindissone. DNA content was
evaluated  by flow cytometry analysis  of  propidium iodide stained  nuclei.  As  shown in  Fig.  2,
flindissone caused in HeLa (Fig. 2A) and in Jurkat (Fig. 2B), an increase of cell population in G0/G1
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and G2/M phases. Moreover, an increase of cells with subG0/G1  DNA content was also observed,
thus indicating the onset of apoptotic events. 
Materials and Methods
General experimental procedures
Optical rotations were measured on a Autopol IV Automatic polarimeter (Rudolph) equipped with a
sodium lamp (589 nm) and a 1 dm microcell. NMR experiments were performed on a Bruker DRX-
600 spectrometer (Bruker BioSpin GmBH) equipped with a Bruker 5 mm TCI CryoProbe at 300 K.
Chemical shifts were expressed in δ (parts per million) referred to the solvent peaks δH 3.34 and δC
49.0 for  CD3OD. The NMR data  were  processed  as  reported  previosuly [15]. HRESIMS were
acquired in the positive and negative ion mode on a LTQ Orbitrap XL mass spectrometer (Thermo
Fisher Scientific). Column chromatographies were performed over silica gel (70-220 mesh, Merck);
RP-HPLC separations were conducted on a  Waters 590 series pumping system equipped with a
Waters R401 refractive index detector, using a C18µ-Bondapak column (30 cm x 7.8 mm, 10 µm,
Waters-Milford) and a mobile phase consisting of MeOH-H2O mixtures at a flow rate of 2 mL/min.
TLC were carried out on precoated Kieselgel 60 F254 plates (Merck); compounds were detected by
Ce(SO4)2/H2SO4 (Sigma-Aldrich) solution. 
Plant material
The aerial  parts of  G.  guidonia (Meliaceae)  were collected in December  2008,  in the  Estación
Experimental  Caparo  (7°  28'  13''  N;  71° 03'  16''  O),  Llanos Occidentales,  Suroeste  del  Estado
Barinas,  Municipio  Ezequile  Zamora,  Venezuela.  The  plant  was  identifed  by  Prof.  Dr.  Pablo
Melendez and a voucher specimen (n. 625) was deposited in the Herbarium MERF of the Facultad
de Farmacia y Bioánalisis, Universidad de Los Andes, Mérida, Venezuela.
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Extraction and isolation
The aerial parts of G. guidonia (400 g) were powdered and successively extracted with n-hexane,
CHCl3, and MeOH (3 × 2 L), to give 6.0 g, 12.1 g, and 15.0 g of the respective dried residues. Part
of the n-hexane extract (5 g) was subjected to column chromatography (5 x 150 cm) over silica gel
eluting with  n-hexane, followed by increasing concentrations of CHCl3  in  n-hexane (between 1%
and 100%) and increasing concentrations of MeOH in CHCl3 (between 1% and 100%). Fractions of
30 mL were collected, analyzed by TLC, and grouped into 9 major fractions (A1-I1).  Fraction D1
(241.0 mg) was purified by RP-HPLC using MeOH–H2O (4:1) to give cneorubin X (2.0 mg, tR 42
min). Fraction F1 (497.2 mg) was chromatographed RP-HPLC using MeOH-H2O (75:25) to yield
cneorubin A (3.5 mg, tR 34 min) and cneorubin B (4.0 mg, tR 38 min). Fraction H1 (274.1 mg) was
subject to RP-HPLC using MeOH-H2O (7:3) to give boscartol C (2.2 mg, tR 37 min) and cneorubin
X  (2.3  mg,  tR 47  min).  Part  of  the  CHCl3 extract  (5.3  g)  was  subjected  to  silica  gel  column
chromatography (5 x 150 cm), eluting with CHCl3 followed by increasing concentrations of MeOH
in CHCl3 (between  1% and 100%).  Fractions of  30 mL were collected,  analyzed by TLC, and
grouped into 10 major fractions (A2-J2). Fractions D2 (990.0 mg) and E2 (264.5 mg) were purified
by  RP-HPLC  with  MeOH-H2O  (85:15)  as  eluent  to  obtain  flindissone  (8.5  mg,  tR 27  min),
compounds 3 (10.0 mg, tR 42 min) and 2 (6.0 mg, tR 50 min), from fraction D2, and compounds 1
(1.2 mg, tR 12 min), 3 (2 mg, tR 42 min), and 2 (2.2 mg, tR 50 min), from fraction E2, respectively.
Fraction  C2 (228.3  mg) was  purified  by  RP-HPLC  using  MeOH-H2O  (3:2)  to  give  7-
acetyldihydronomilin  (1.2 mg,  tR 22 min). Finally, fraction H2 (145.0 mg) was subjected to RP-
HPLC using MeOH-H2O (9:1) to give picroquassin E (2.3 mg, tR 45 min). 
Guareolide (1)  -143 (c 0.1, MeOH);  1H and  13C NMR data, see
Table 1; HRESIMS: m/z 491.3122 [M+Na]+ (calcd. for C30H44NaO4, 491.3137).
Guareoic acid A (2): white amorphous powder; +11.5 (c 0.09, MeOH); 1H and 13C NMR data,
see Table 1; HRESIMS: m/z 469.6838 [M-H]- (calcd. for C30H45O4, m/z 469.3318).
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Guareoic acid B (3): white +139 (c 0.27, MeOH); 1H and 13C NMR data,
see Table 1; HRESIMS: m/z 453.3329 [M-H]- (calcd. for C30H45O3, m/z 453.3369).
Cytotoxicity assay
Cells and treatment
Jurkat, HeLa, and MCF-7 cell lines were obtained from the American Type Cell Culture (ATCC).
Cells were maintained in DMEM (HeLa and MCF-7) or RPMI 1640 (Jurkat), supplemented with
10% fetal bovine serum,100 mg/L streptomycin and penicillin 100 IU/mL at 37 °C in a humidified
atmosphere  of  5% CO2.  To ensure logarithmic growth,  cells  were subcultured every  two days.
PBMC were isolated from buffy coats of healthy donors (kindly provided by the Blood Center of
the Hospital of Battipaglia, Salerno, Italy) by using a standard Ficoll–Hypaque gradient. Freshly
isolated PBMC contained 90.6 ± 1.2% live cells as assessed by the manual Trypan blue exclusion
method. Stock solutions (50 mM) of purified compounds in DMSO were stored in the dark at 4 °C.
Appropriate dilutions were prepared in culture medium immediately prior to use. In all experiments,
the final concentration of  DMSO did not exceed 0.15% (v/v). 
Cell viability and cell cycle 
Cells were seeded in 96-well plates and incubated for the established times in the absence (vehicle
only) and in the presence of different concentrations of compounds. The day before treatments, cells
were seeded at a cell density of 1×104 cells/well. The number of viable cells was quantified by MTT
assay. Absorption at 550 nm for each well was assessed using a microplate reader (LabSystems). In
some experiments cell viability was also checked by Trypan Blue exclusion assay using a Bürker
counting  chamber. EC50 values  were  calculated  from  cell  viability  dose–response  curves  and
defined as the concentration resulting in 50% inhibition in cell survival as compared to etoposide
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(E1383, Etoposide synthetic, ≥98%, Sigma-Aldrich), used as positive control. Each experimental
condition was tested once in quadruplicate. EC50 values were performed with GraphPad software.
Cell cycle was evaluated by propidium iodide (PI) staining of permeabilized cells according to the
available protocol and flow cytometry (BD FACSCalibur flow cytometer, Becton Dickinson) [16].
Data  from  5000  events  per  sample  were  collected.  The  percentages  of  the  elements  in  the
hypodiploid region and in  G0/G1, S and G2/M phases  of the cell cycle were calculated using the
CellQuest or MODFIT software, respectively.
Supporting information
NMR spectra  of  compounds  1-3 and  data  for  the  EC50 determination  of  cytotoxic  activity  are
available as Supporting Information.
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Figure legend:
Fig. 1 Chemical structures of compounds 1-3 isolated from G. guidonia aerial parts
Fig. 2  Effect of flindissone on cell proliferation. Flow cytometric evaluation of DNA content in
cells exposed for 48 h to flindissone or vehicle alone (controls). (A) HeLa cells were exposed to 15
µM and 35 µM flindissone; (B) Jurkat cells exposed to 15 µM and 35 µM flindissone. Data in (A)
and (B) have been subtracted for the corresponding values  in control  cells  (exposed to  vehicle
only): HeLa, subG0/G1 ≤ 2%; G0⁄G1, 53 ± 1.9%; S, 37 ± 2.2%; G2⁄M, 10  ± 0.3.%; Jurkat, subG0/G1
≤ 2.2%;  G0⁄G1, 56 ± 1.8%; S, 37 ± 2.1%; G2⁄M, 6 ± 0.9%.  Data are the mean values from three
experiments: SD values never exceeded 12% of the means. 
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Table 1 1H and 13C-NMR data of compounds 1-3 (CD3OD, 600 MHz, J in Hz)
position 1 2 3
δH δC δH δC δH δC
1a 1.96 br dd (14.7, 8.0) 35.0 1.28 m 32.0 1.40 32.8
1b 1.50a
2a 3.00 br dd (14.0, 10.0) 30.5 2.00a 30.0 2.38 ddd (15.5, 11.0, 3.8) 29.1
2b 2.44 br dd (14.5, 7.6) 1.80a 2.21a
3 178.0 178.0 175.0
4 148.0 149.0 148.3
5 2.74 dd (14.5, 2.5) 46.9 2.47 dd (12.0, 6.0) 50.4 2.49 dd (12.0, 6.0) 50.5
6a 2.03 m 28.3 2.24 m 31.3 2.24a 31.2
6b 1.57a 2.03a 2.03a
7 4.12 br s 64.0 5.26 br d (3.5) 119.1 5.39 br d (3.0) 119.5
8 145.8 147.0 147.9
9 133.2 2.60 m 42.2 2.57 m 42.2
10 41.5 37.9 38.0
11 5.18 br d (5.6) 75.1 1.61a 18.0 1.61a 18.7
12a 2.16a 39.3 1.63a 33.0 1.72a 32.7
12b 1.70a 1.50a 1.63a
13 43.0 45.0 44.8
14 52.4 52.0 52.0
15a 2.06 ddd (17.0, 13.0, 3.5) 35.3 1.99a 36.7 1.65 35.5
15b 1.69a 1.50a 1.52 m
16a 1.50a 30.8 1.70a 34.4 1.72a 32.5
16b 1.37a 1.63a 1.49a
17 1.78a 49.7 2.11 br dd (15.0, 9.4) 46.0 1.72a 52.9
18 1.07 s 19.7 0.94 s 24.0 0.92 s 23.4
19 1.09 s 20.2 0.86 s 16.0 0.87 s 16.2
20 2.35 m 43.4 2.02a 49.0 2.05a 43.5
21a 4.15 t (8.5) 72.8 4.83a 104.0 4.01 t (8.3) 73.0
21b 3.24 t (8.5) 3.28 br t (9.2)
22a 2.20a 39.1 1.72a 37.0 1.72a 39.6
22b 1.79a 1.50a
23 4.67 ddd (13.5, 8.0, 5.0) 76.0 4.76 ddd (13.0, 8.3, 4.6) 76.4 4.65 ddd (13.3, 8.5, 4.6) 75.5
24 5.24 br d (8.3) 127.6 5.18 br d (9.0) 128.9 5.20 br d (8.4) 127.1
25 138.0 135.0 138.0
26 1.73 s 18.3 1.69 s 18.0 1.70 s 17.9
27 1.72 s 25.9 1.72 s 26.0 1.72 s 25.0
28a 5.01 br s 115.8 4.86a 114.4 4.89a 114.6
28b 4.80 br s 4.84a 4.85a
29 1.82 s 24.0 1.81 s 23.0 1.81 s 22.8
30 0.93 s 25.9 1.06 s 27.0 1.05 s 27.9
Data assignments were confirmed by DQF-COSY, 1D-TOCSY, HSQC, and HMBC experiments.
a Overlapped signal.
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Table 2 EC50 (µM) antiproliferative activity of isolates in different cell lines
compound Jurkata HeLab MCF7c PBMCd
1 ›100 ›100 ›100 -
2 39 55 75 ›100
3 ›100 ›100 ›100 -
flindissone 25 27 50 ›100
picroquassin E 88 ›100 ›100 -
etoposide 2.5 4 12 -
aT-cell leukemia; bcervical carcinoma; cbreast carcinoma; dhuman peripheral
blood mononuclear cells
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